Utility of 99mTc dextran scintigraphy in diabetic patients with suspected osteomyelitis of the foot

Annals of Nuclear Medicine

Volumn 17, Issue 8, 2003, Pages 669-676

  Sarikaya, Ali ^a   Aygit, A Cemal ^a   Pekindil, Gökhan ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

99mTc dextran; Diabetic foot; Infection; Scintigraphy

Indexed keywords

DEXTRAN TC 99M; MEDRONATE TECHNETIUM TC 99M; DEXTRAN; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M DEXTRAN;

ADULT; AGED; ARTHROPATHY; ARTICLE; BONE LESION; BONE SCINTISCANNING; CLINICAL ARTICLE; CLINICAL TRIAL; DECUBITUS; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC FOOT; DIABETIC NEUROPATHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; FOOT OSTEOMYELITIS; FOOT ULCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; OSTEOMYELITIS; PRIORITY JOURNAL; TISSUE NECROSIS; ADOLESCENT; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DEXTRANS; DIABETIC FOOT; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; OSTEOMYELITIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 1042279673     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02984973     Document Type: Article

References (23)

1. Bhatnagar A, Mishra P, Singh AK, Taneja V, Chauhan UP, Sawroop K. Scintiscan demonstration of localized bowel loop inflammation. Comparison of Tc-99m dextran, Tc-99m citrate, and Tc-99m human immunoglobulin G. Clin Nucl Med 1996; 21: 685-688.
2. m-dextran: a potential inflammation-seeking radiopharmaceutical. Nucl Med Commun 1995; 16: 1058-1062.
3. Sankaya I, Bektas A, Ibis E, Yasa MH, Bastemir M, Ormeci N, Aras G. Tc-99m dextran and Tc-99m HIG findings in patients with ulcerative colitis. Clin Nucl Med 1999; 24: 243-247.
4. 99mTc and its evaluation for lymphoscintigraphy. Nucl Med Biol 1993; 20: 701-706.
5. Palestro CJ, Cohen IR, Goldsmith SJ. Wound dressing activity mimicking infection on labeled leukocyte imaging. Clin Nucl Med 1992; 17: 711-713.
6. Eckman MH, Greenfield S, Mackey WC, Wong JB, Kaplan S, Sullivan L, et al. Foot infections in diabetic patients. Decision and cost-effectiveness analyses. JAMA 1995; 1273: 712-720.
7. Greenspan A, Stadalnik RC. A musculoskeletal radiologist's view of nuclear medicine. Semin Nucl Med 1997; 27: 372-375.
8. Tomas MB, Patel M, Marwin SE, Palestro CJ. The diabetic foot. Br J Radiol 2000; 73: 443-450.
9. Schauwecker DS. The scintigraphic diagnosis of osteomyelitis. Am J Roentgenol 1992; 158: 9-18.
10. Becker W. Imaging osteomyelitis and the diabetic foot. Q J Nucl Med 1999; 43: 9-20.
11. Palestro CJ, Tomas MB. Scintigraphic evaluation of the diabetic foot. Edited by Freeman LM, Nuclear Medicine Annual 2000, Philadelphia; Lippincott Williams & Wilkins, 2000; 143-172.
12. Johnson JE, Kennedy EJ, Shereff MJ, Patel NC, Collier BD. Prospective study of bone, indium-111-labeled white blood cell, and gallium-67 scanning for the evaluation of osteomyelitis in the diabetic foot. Foot Ankle Int 1996; 17: 10-16.
13. Palestro CJ, Mehta HH, Patel M, Freeman SJ, Harrington WN, Tomas MB, et al. Marrow versus infection in the Charcot joint: indium-111 leukocyte and technetium-99m sulfur colloid scintigraphy. J Nucl Med 1998; 39: 346-350.
14. Seabold JE, Flickinger FW, Kao SC, Gleason TJ, Kahn D, Nepola JV, et al. indium-111-leukocyte/technetium-99m-MDP bone and magnetic resonance imaging: difficulty of diagnosing osteomyelitis in patients with neuropathic osteoarthropathy. J Nucl Med 1990; 31: 549-556.
15. Devillers A, Moisan A, Hennion F, Garin E, Poirier JY, Bourguet P. Contribution of technetium-99m hexamethylpropylene amine oxime labelled leucocyte scintigraphy to the diagnosis of diabetic foot infection. Eur J Nucl Med 1998; 25: 132-138.
16. 99mTc-labelled anti-granulocyte antibodies. Nucl Med Commun 1993; 14: 212-218.
17. Devillers A, Garin E, Polard JL, Poirier JY, Arvieux C, Girault S, et al. Comparison of Tc-99m-labelled antileukocyte fragment Fab′ and Tc-99m-HMPAO leukocyte scintigraphy in the diagnosis of bone and joint infections: a prospective study. Nucl Med Commun 2000; 21: 747-753.
18. Oyen WJ, Netten PM, Lemmens JA, Claessens RA, Lutterman JA, van der Vliet JA, et al. Evaluation of infectious diabetic foot complications with indium-111-labeled human nonspecific immunoglobulin G. J Nucl Med 1992; 33: 1330-1336.
19. 99mTc-nanocolloid scintigraphy for assessing osteomyelitis in diabetic neuropathic feet. Clin Radiol 1998; 53: 120-125.
20. Henze E, Schelbert HR, Collins JD, Najafi A, Barrio JR, Bennett LR. Lymphoscintigraphy with Tc-99m-labeled dextran. J Nucl Med 1982; 23: 923-929.
21. Henze E, Robinson GD, Kuhl DE, Schelbert HR. Tc-99m dextran: a new blood-pool-labeling agent for radionuclide angiocardiography. J Nucl Med 1982; 23: 348-353.
22. Nijhof MW, Oyen WJ, van Kampen A, Claessens RA, van der Meer JW, Corstens FH. Evaluation of infections of the locomotor system with indium-111-labeled human IgG scintigraphy. J Nucl Med 1997; 38: 1300-1305.
23. Ezuddin S, Yuille D, Spiegelhoff D. The role of dual bone and WBC scan imaging in the evaluation of osteomyelitis and cellulitis using both planar and SPECT imaging. JNucl Med 1992; 33: 839.